NCT05132569 2025-09-09
URSA
Sanofi
Phase 3 Terminated
Clinical Trials
4 trialsNCT04963270 2025-02-28
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
Hoffmann-La Roche
Phase 3 Terminated
NCT03579966 2024-05-07
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Catalyst Pharmaceuticals, Inc.
Phase 3 Terminated
NCT00995722 2017-06-02
EPITOME'
University of Miami
Phase 3 Terminated